EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access

Bioactive Natural and Synthetic Chalcones: Brazil as a Research Powerhouse in Discovery and Innovation

Patrick Rômbola Ozanique, Wellington Negri Tondato, Alvaro Luiz Helena, Luis Octavio Regasini

ChemMedChem · 2026-08-14 · 21 (15)

DOI: 10.1002/cmdc.70367 ↗

At a glance

Übersichtsarbeit in ChemMedChem, published online on 2026-08-04. Written by Patrick Rômbola Ozanique and 3 co-authors. Institution: Department of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities, and Exact Sciences (IBILCE), São Paulo State University (UN…. Major MEDLINE topics: Chalcones, Drug Discovery, Biological Products, Antineoplastic Agents. Cited 1 times so far (Crossref); 139 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Chalcones (1,3‐diphenyl‐2‐propen‐1‐one) are open‐chain flavonoids recognized for their structural diversity and broad pharmacological activities. Electrophilic α,β‐unsaturated carbonyl systems and versatile substitution patterns on aromatic rings have positioned the chalcones as privileged structures in medicinal chemistry. This review highlights the contributions of Brazilian investigations to the advances of chemistry and bioactivity of natural and synthetic chalcones over the last 40 years. A systematic search of PubMed, Scopus, Embase, and Web of Science up to February 2026 identified 661 publications, revealing a growing interest since the early 2000s and reflecting the consolidation of chalcone as a central subject of research groups. Brazilian investigations have shown chalcones as antibacterial, antifungal, antiparasitic, anticancer, and anti‐inflammatory agents, affording pivotal insights into structure–activity relationships and mechanisms of action at the molecular level. In addition, we submitted the most active chalcones to in silico evaluations, using SwissADME web tool, allowing a comparative analysis of their physicochemical, pharmacokinetics, and drug‐likeness properties. The results indicated the majority of these compounds demonstrated an appropriate drug‐like behavior. Collectively, the set of findings has positioned Brazil as an important research powerhouse of chemistry and pharmacology of chalcone and its derivatives, which may impact the discovery of innovative therapeutic agents.

Subjects

MeSH terms (MEDLINE)

ChalconesDrug DiscoveryBiological ProductsAntineoplastic AgentsAnti-Inflammatory AgentsAntiparasitic AgentsAntifungal AgentsAnti-Bacterial AgentsHumansBrazilStructure-Activity RelationshipMolecular StructureAnimals

Author keywords

BrazilBrazilian researchchalconesmedicinal chemistrynatural products

Substances

ChalconesBiological ProductsAntineoplastic AgentsAnti-Inflammatory AgentsAntiparasitic AgentsAntifungal AgentsAnti-Bacterial Agents

Authors and institutions

  • Department of Chemistry and Environmental Sciences, Institute of Biosciences, Humanities, and Exact Sciences (IBILCE), São Paulo State University (UNESP), São José do Rio Preto, Brazil.

Cite

APA

Ozanique, P. R., Tondato, W. N., Helena, A. L., & Regasini, L. O. (2026). Bioactive Natural and Synthetic Chalcones: Brazil as a Research Powerhouse in Discovery and Innovation. ChemMedChem, 21(15). https://doi.org/10.1002/cmdc.70367

Vancouver

Ozanique PR, Tondato WN, Helena AL, Regasini LO. Bioactive Natural and Synthetic Chalcones: Brazil as a Research Powerhouse in Discovery and Innovation. ChemMedChem. 2026;21(15). doi:10.1002/cmdc.70367

BibTeX
@article{Ozanique2026,
  author = {Ozanique, Patrick Rômbola and Tondato, Wellington Negri and Helena, Alvaro Luiz and Regasini, Luis Octavio},
  title = {Bioactive Natural and Synthetic Chalcones: Brazil as a Research Powerhouse in Discovery and Innovation},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {15},
  doi = {10.1002/cmdc.70367}
}
Start for free →